Skip to main content
Equibles
SIBN logo

SIBN · SI-BONE, Inc.

Track SIBN — free

Use SIBN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$18.50 -0.14 (-0.75%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$829.14M
Shares
44.82M

SIBN metrics

69 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$18.50
Market cap
$829.14M

Price action

19 metrics
Price change (1W)
-3.7%
Price change (30D)
-0.6%
Price change (3M)
+22.4%
Price change (6M)
+33.8%
Price change (YTD)
-6.2%
Price change (1Y)
+13.1%
Trailing year
Price change (5Y)
-26.2%
52-week high
$21.40
52-week low
$11.61
Change from 52-week high
-13.6%
Change from 52-week low
+59.3%
Annualized volatility
49.0%
Beta
0.7
RSI (14D)
46.9
Price vs SMA 50
+2.1%
Price vs SMA 200
+12.8%
Avg volume (3M)
551,894
Relative volume
0.7
Average dollar volume
$9.73M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
44.82M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.9×
reciprocal yield 25.6%
P / book
4.6
reciprocal yield 21.8%
FCF yield
-0.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
337.1
reciprocal yield 0.3%
Earnings yield
-1.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
4.2×
reciprocal yield 23.7%
EV / revenue historical average (5Y)
5.3×
reciprocal yield 19.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-03

Profitability

9 metrics
Gross margin
79.5%
Operating margin
-8.3%
Trailing 12 months
Net margin
-6.9%
Gross profit (TTM)
$169.87M
Operating profit (TTM)
−$17.75M
Net income (TTM)
−$14.63M
Trailing 12 months
Diluted EPS (TTM)
$-0.34
FCF margin
-2.1%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-35.91

Growth

11 metrics
Revenue growth YoY
+15.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$213.60M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.9%
Year over year · more shares
Revenue CAGR (3Y)
+23.6%
Revenue CAGR (5Y)
+22.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-8.0%
Return on assets
-5.9%
Debt / equity
—
Current ratio
9.1
EBITDA (TTM)
−$11.32M
Free cash flow (TTM)
−$4.39M
Quick ratio
7.6
Interest coverage
-7.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$33.13M
Total assets
$248.76M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.48M
Capital expenditures (TTM)
$6.87M
R&D (TTM)
$18.02M
SG&A (TTM)
—
Stock compensation (TTM)
$24.21M
R&D / revenue
8.4%
Stock compensation / revenue
11.3%

Ownership (13F)

3 metrics
13F filers
170
13F filer change QoQ
-10
Institutional ownership
106.8%

Short interest

3 metrics
Short interest
11.9%
Latest settlement · 10.9 days to cover
Days to cover
10.9d
Short-squeeze score
83 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$3.47M
Insider-sentiment score
21 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1459839 CUSIP 825704109 13F (30d) 134 filings 132 filers Visit website Investor relations